Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
2019
AbstractBackground: Dupilumab, a fully human monoclonal antibody targeting the alpha subunit of IL-4 was recently approved for the treatment of moderate-to-severe atopic dermatitis (AD) in adult pa...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
21
References
36
Citations
NaN
KQI